Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Eugenia aurata and Eugenia punicifolia HBK inhibit inflammatory response by reducing neutrophil adhesion, degranulation and NET release

  • Mírian Feliciano Costa1,
  • Tais Iara Jesus1,
  • Bruno Rafael Pereira Lopes1,
  • Célio Fernando Figueiredo Angolini2,
  • Abner Montagnolli1,
  • Lorraine de Paula Gomes1,
  • Gabriela Sterle Pereira1,
  • Ana Lucia Tasca Gois Ruiz3,
  • João Ernesto Carvalho4,
  • Marcos Nogueira Eberlin2,
  • Catarina dos Santos1 and
  • Karina Alves Toledo1Email author
BMC Complementary and Alternative MedicineBMC series – open, inclusive and trusted201616:403

https://doi.org/10.1186/s12906-016-1375-7

Received: 14 July 2016

Accepted: 4 October 2016

Published: 22 October 2016

Abstract

Background

Eugenia spp. are used in popular medicine in the treatment of pain, diabetes, intestinal disorders and cough. The aim of the work is to evaluate, ex vivo and in vivo, the anti-inflammatory activity of the hydroethanolic extracts of the leaves of Eugenia aurata (EA) and Eugenia punicifolia HBK (EP) upon neutrophils.

Methods

Ex vivo, isolated human neutrophils were sensitized by Eugenia extracts (0.1–1000 μg/mL) and stimulated by PMA. In these conditions, different neutrophil activities related to inflammatory process were measured: adhesion, degranulation and NET release. Neutrophil viability and tumor line cells were monitored. In vivo, neutrophil influx was evaluated by peritonitis model performed in mice pretreated with different concentrations of Eugenia extracts. Phytochemical profile was assessed by mass spectrometry.

Results

Ex vivo, EA and EP (1000 μg/mL) reduced cell adhesion and degranulation, respectively. NET release was inhibited by EA and EP. Anti-inflammatory activities occurred in the absence of cytotoxicity. In vivo, both EA as EP inhibited neutrophil migration. The phytochemical profile revealed that EA contains myricitrin, rutin, quinic acid and quercetin derivatives. EP presents gallic acid, quercetin derivatives, syringic acid, ellagic acid, monogalloyl-glucose, glycosyringic acid, mudanoside B, HHDP glucose isomer and digalloylglucose isomer. EA and EP inhibit neutrophil migration by different pathways.

Conclusion

Different chemical compositions may explain the anti-inflammatory effects described herein for EA and EP. Both extracts inhibit NET release but only EA reduces cell adhesion whereas EP decreases elastase secretion. This work contributes to the elucidation of cellular mechanisms related to the anti-inflammatory activity for leaves of E. aurata and E. punicifolia HBK.

Keywords

Inflammation Neutrophils Eugenia aurata Eugenia punicifolia (HBK) Adhesion Elastase

Background

Inflammation is a process that includes a complex immune response, which occurs in several steps and may be caused by chemical, physical, microbiological and immunological stimuli. It involves leukocyte recruitment where the first leukocytes to be recruited and act on the inflamed tissue are neutrophils. Neutrophils have been considered a target for pharmacological intervention given their abilities to kill microorganisms, to begin and amplify the inflammatory process. Neutrophil recruitment and inflammatory activities require a complex sequence of events, including cell adhesion, degranulation, and more recently, neutrophil extracellular traps (NET) release [1]. The control of the inflammatory process is critical because of the associated risks: tissue damage, loss of organ performance and failure.

Eugenia genus with over 500 species, of which about 400 are in Brazil, assumes prominence in popular medicine, mainly for their anti-inflammatory activities in the treatment of wounds and infections [2, 3]. Flavonoids, tannins, terpenoids and essentials oils were isolated from this genus [4, 5]. Different crude extracts of Eugenia show several medicinal effects, such as anti-inflammatory [6], antifungal [7], neurological [8], antimicrobial [9], among others. Leaves of Eugenia punicifolia are popularly used to treat inflammation [10], diabetes [6, 10], fever and flu [11, 12]. E. aurata is an endangered species [13] with low studies in the literature and, by analogy, there is a need of registering its effects on inflammatory processes.

Although leaves of Eugenia species are widely used in popular medicine for inflammatory diseases, efficacy of cellular and molecular mechanisms remains elusive. Our aim was to evaluate the cellular mechanisms involved in the anti-inflammatory activity of Eugenia aurata and Eugenia punicifolia. For this purpose, ex vivo assays were performed and the anti-inflammatory activity was confirmed using in vivo assays.

Methods

Collection and preparation of extract

Leaves of E. punicifolia and E. aurata were collected in December (2009) in Assis (Instituto Florestal e Estações Experimentais – Floresta Estadual de Assis) at the point (UTM 0561750 L/O 7500935 (+/- 3 m) - 0559055 L/O 7499970 (+/- 4 m)), São Paulo State, Brazil. Dr. Antônio C.G. Melo identified the specimen and voucher specimen (n° 43.522 and 43520, respectively) were deposited in Herbarium D. Bento Pickel for future reference. The extract has been prepared with 10 g of plant material (dried and triturated leaves) and 100 ml of solvent (Ethanol:H2O 70:30 v/v). The extract solution was obtained by 2 h dynamic maceration at room temperature (25 ± 2 °C), followed by filtration. Remaining extract residue filtration was carried twice by the same procedure. Subsequently, the solution was dried at 40 °C temperature with a rotary evaporator, obtaining 45 % and 7 % hydroethanolic extract solutions from E. punicifolia (HEEP) and E. aurata (HEEA), respectively. The hydroethanolic extract fraction soluble in Phosphate Buffer Solution (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4) was evaluated in all bioassays (Eugenia aurata = EA; Eugenia punicifolia = EP).

Animals

Swiss male mice, weighing on average 40 grams, were kept in controlled temperature rooms (23–25 °C) with access to food and water. All animal care and experimental procedures were performed in accordance with the internationally accepted principles for laboratory animal use [14].

Human neutrophils isolation

Human neutrophils were isolated and prepared according to previous methods described [15, 16]. Cells were suspended in Hank´s balanced salt solution (HANKS) (Sigma, St. Louis, MO, USA) containing 0.1 % gelatin (w/v) (HANKS-gel) with over 90 % viability as determined by the Trypan blue (Sigma) exclusion test, and 90–95 % of cells were found to be neutrophils.

Cell viability (MTT assay)

Cytotoxicity was evaluated by the colorimetric method of MTT (3-(4,5-dimethylthiazol-2-yl) 2,5-Diphenyl Tetrazolium bromide) (Sigma), which consists of indirectly measuring of cell viability by mitochondrial enzyme activity of living cells. Human neutrophils (2 x 105 / well) seeded into 96 well culture plates were incubated with different concentrations of Eugenia spp. during 1 h at 37 °C. Subsequently, MTT (1 mg/mL) was added to each well and incubated at 37 °C for 4 h. After incubation, formazan crystals were diluted by addition of Dimethyl Sulfoxide (DMSO, Sigma) and the optical density (O.D.) of samples measured in a spectrophotometer at 570 nm. Neutrophils incubated either with RPMI-1640 (Sigma) or 50 μM H2O2 [17] were used as negative and positive control (100 % viable) to cell death, respectively.

Cell adhesion

Cell adhesion assays were performed in 96 well micro plates. Human neutrophils (4 x 105) suspended in RPMI medium (Sigma) plus 5 % Fetal Bovine Serum (FBS) (Vitrocell, Campinas, SP, Brazil) were added to wells of a micro plate containing different concentrations of Eugenia spp. After 15 min, cells were then stimulated by Phorbol Myristate Acetate (PMA 25nM) (Sigma) for 1 h at 37 °C. Non-adherent cells were removed and adherent cells were made evident via a colorimetric test with Bicinchoninic Acid (BCA; Pierce). Sample absorbance was measured in a Multiskan FC (Thermo Scientific, Waltham, MA, USA) reader at 560 nm.

Elastase activity

Elastase enzyme activity upon degranulation was assessed as follows: Neutrophils (2 x 105) suspended in Hank's solution were incubated for 30 min in the presence of different Eugenia spp. concentrations then stimulated with PMA (25nM) for 3 h at 37 °C. Succeeding incubation, neutrophils were centrifuged (437 x g, 5 min) and the resulting supernatants incubated in 1 mM elastase substrate (N-Methoxysuccinyl-Ala-Ala-Pro-Val p-nitroanilide) (Sigma) for 30 min. After incubation, color reaction was measured at 405 nm on microplate reader Multiskan FC (Thermo Scientific). Several concentrations of purified elastase enzyme from human neutrophils (EMD Chemicals Inc., Billerica, MA, USA) were used as standards.

Neutrophil Extracellular Traps (NETs) release

Human neutrophils (2 x 105) were incubated with different concentrations of Eugenia spp. during 30 min and then stimulated with PMA (50 nM) for 4 h at 37 °C. NETs generated by activated neutrophils were digested with 500 mU/mL micrococcal nuclease (MNase, Worthington Biochemical Corp.) [18]. The nuclease activity was ceased by 5 mM Ethylene Diamine Tetra Acetic Acid (EDTA) and the culture supernatant collected and stored at 4 °C until the moment of quantification. NETs were quantified using the PicoGreen dsDNA kit (Invitrogen) according to the manufacturer's recommendations.

Peritonitis model (in vivo)

Mice received 1 mL of 3 % Thioglycolate injected intraperitoneally one hour after plant extract subcutaneous administration (3-300 mg/kg) [19, 20]. Six hours later, mice were euthanized by cervical dislocation. The cells were immediately harvested with 5 mL PBS containing heparin (5 IU/mL). Total counts of harvested cells were performed in a Neubauer chamber. Differential counts were made on smears stained using Panoptic Fast Stain (LaborClin, Siqueira Campos, PR, Brazil). The results were reported as the number of neutrophils per mL of cavity wash. The control groups animals received: (1) subcutaneous and intraperitoneal PBS injection; (2) subcutaneous PBS and intraperitoneal Thioglycolate injection; (3) subcutaneous Dexamethasone (0.5 mg/kg) and intraperitoneal Thioglycolate injection.

Evaluation of antiproliferative activity in vitro

Antiproliferative activity was tested against cell lines: UACC-62 (melanoma); MCF-7 (mammary); NCI-ADR/RES (drug resistant ovary); 786-0 (kidney); NCI-H460 (lung); PC-3 (prostate); OVCAR-3 (ovary); HT-29 (colon), K562 (leukemia) and VERO (African green monkey kidney cell line). Stock cultures were grown in a medium containing 5 mL RPMI 1640 (Sigma) supplemented with 5 % fetal bovine serum. Gentamicin (50 mg/mL) was added to experimental cultures. Cells in 96 well plates (100 μL cells/well) were exposed to sample concentrations of DMSO/RPMI (0.25, 2.5, 25, and 250 μg/mL) at 37 °C, 5 % CO2 in air for 48 h. Next, cells were fixed with 50 % trichloroacetic acid and cell proliferation was determined employing sulforhodamine B assay at 540 nm [21]. Using the concentration–response curve for each cell line, TGI (concentration that produces total growth inhibition or cytostatic effect) was determined through non-linear regression analysis, utilizing software ORIGIN 8.5 (OriginLab Corporation) [22].

Phenolic content

Phenolic content was performed as previously described [23] with minor adaptations. Briefly, 2.5 mL Folin-Ciocalteau 10 % (v/v) and 2.0 mL 4 % (m/v) sodium carbonate were added to a 0.5 mL extract in ethanol solution (1 mg/mL). After a 2 h incubation in the dark, at room temperature, absorbance was measured at 750 nm and results were expressed as equivalent milligrams of gallic acid per gram of sample. All tests were performed in triplicate.

Flavonoid content

Flavonoid content was performed as previously described [23] with minor adaptations. Briefly, 1.5 mL ethanol, 0.1 mL potassium acetate (1 M) and 2.8 mL distilled water were added to a 0.5 mL extract in ethanol solution (1 mg/mL). After 30 min incubating in the dark at room temperature, absorbance was measured at 425 nm and results were expressed as equivalent milligrams of quercetin acid per gram of sample. All tests were performed in triplicate.

ESI-MSn analysis

The mass spectrometry experiments were performed on a 6550 iFunnel Q-TOF (Agilent Technologies). The studied matrix was analyzed by Dual Agilent Jet Stream ESI (Dual-AJS-ESI) (ESI) and fragmented in the MS/MS collision cell. The negative mode was selected for the generation and analysis of first order mass spectra (MS) and the remaining multistage experiments under the following conditions: Gas Temp at 290 °C, Drying Gas flow at 11 Lmin−1, Nebulizer at 45 psi, Sheath gas temp at 350 °C, Sheath gas flow 12 Lmin−1, VCap 3000, Nozzle voltage 320 V, Fragmentor 100 V, OCT 1 RFVpp 750 V, and collision energy 35 V Agilent MassHunter Qualitative Analysis software version B.06.00 used for data acquisition and processing.

Statistical analysis

Experimental data was evaluated by variance analysis (one-way ANOVA) followed by Bonferroni test. A significance level of 5 % was adopted. All assays were performed in triplicate at least in three independent assays.

Results and discussion

Inflammatory process involves cellular and molecular events that begin with neutrophil recruitment. This process is commonly separated in four steps: rolling, adhesion, transmigration and degranulation. The rolling is mediated by the interaction between neutrophil selectins (selectin- L) and endothelium selectin (selectins P and E). Sequentially, the adhesion happens by the interaction between endothelium and neutrophil integrins as well as by mobilization of neutrophil secretory vesicles. After that, the transmigration - or diapedesis – also occurs under effect of integrins interactions and counting on the help of release of neutrophil tertiary granules to digest endothelium basal membrane. Finally, the proteins released from neutrophil secondary/primary granules can be associated with DNA and oxidative enzymes, also called NETs. The release of NETs improves microbe capture, as well as increases phagocytosis efficiency [1, 24].

The cellular mechanisms related to the anti-inflammatory activity of E. punicifolia (EP) and E. aurata (EA) were evaluated. Therefore, some neutrophil functions were analysed ex vivo and others in vivo because neutrophils are the first inflammatory cells to be recruited to the damaged tissue. Both Eugenia extracts were able to inhibit neutrophils responses, by different pathways, under clear evidence of no toxicity for the cells.

Ex vivo assays aimed the evaluation of the role of EA and EP in adhesion, elastase secretion and NET release. In the first step, adhesion, neutrophils incubated with 25 nM PMA and adhered to the culture plate were considered as 100 % adhesion (Fig. 1). Neutrophils incubated only with culture medium RPMI-1640 showed basal adhesion rate (~50 %). Pretreatment of neutrophils with several EP concentrations did not alter their ability to adhere under PMA stimulus. On the other hand, pretreatment with EA 1000 μg/mL significantly reduced cell adhesion. EP (1000 μg/mL) was the only concentration able to induce a weak neutrophil adhesion when neutrophils were incubated with extracts alone (data not shown), although this effect has not been statistically significant.
Fig. 1

Eugenia aurata (EA) inhibits human neutrophil adhesion. Human neutrophils (4x105) were pretreated with different concentrations of EA or EP (15 min) and stimulated (1 h) to adhesion by PMA (25nM). Neutrophils incubated with RPMI alone were used as negative control. Data are shown as cell adhesion (%) ± S.D. where PMA is 100 %. p <0.05 when compared to PMA (*) or medium (#) control

The second step was to evaluate elastase secretion, indirectly assessed through elastase enzyme activity. Supernatants of cultures of neutrophils stimulated by PMA (25nM) and previously sensitized by plant extracts were analyzed. The release of elastase induced by PMA was considered as100%. Neutrophils incubated with medium alone showed significant reduction (Fig. 2). The presence of EA did not alter elastase secretion at any tested concentration . However, EP 1000 μg/mL significantly reduced PMA induced elastase secretion. None of the extract concentrations in test was able to induce elastase secretion (data not shown).
Fig. 2

Eugenia punicifolia (EP) inhibits human neutrophil elastase secretion. Human neutrophils (4x105) were pretreated with different concentrations of EA or EP (30 min) and stimulated to degranulation by PMA (25nM) for 3 h. Neutrophils incubated with only Hank´s (medium) were used as negative control. Data shown Elastase activity (%) ± S.D. where PMA is 100 %. p <0.01 when compared to PMA (**) or medium (##) control

Next inflammatory event evaluated was the release of NETs. The presence of both plant extracts studied here inhibited significantly the release of NETs induced by PMA (50nM) for all tested concentrations (0.1–1000 μg/mL) (Fig. 3). The positive control (50nM PMA) induced DNA release of 230 ng/ml while negative control (Medium) showed ~50 ng/mL. The inhibition of this event may have a suppressive effect on inflammation, activation of neutrophils and capture/elimination of pathogens by decreasing the inflammatory stimulus that comes from genetic material released. Furthermore, the presence of extracellular DNA (NETs) has been appointed as a direct source of stimulus to inflammatory and autoimmune diseases [1].
Fig. 3

Eugenia spp. extracts inhibit NET release induced by PMA. Human neutrophils (4x105) were pretreated with different concentrations of E. aurata (EA) or E.punicifolia (EP) (0.1-1000 μg/mL) and stimulated to NET release for 4 h by 50nM PMA. Neutrophils incubated with PMA or Hank´s (medium) alone were used as positive and negative control, respectively. Data shown as released DNA (ng/mL) ± S.D. p <0.01 when compared to PMA (*) or medium (#) control

Neutrophil viability was monitored during all ex vivo assays. This is an important factor once some inhibitory effects could be related to cytotoxicity. The viability was assessed by MTT assay. The data revealed that the extracts, evaluated in different concentrations (0.1–1000 ug/mL), did not reduce neutrophil viability when these cells were sensitized either with EP or with EA (Fig. 4). As positive and negative controls, H2O2 and RPMI medium were used. H2O2 (50 μM) reduced 70 % of cell viability.
Fig. 4

Neutrophils viability is not affected by Eugenia aurata (EA) or E. punicifolia (EP). Human neutrophils (4x105) were incubated with different concentrations of EA or EP. At the end of incubation, cell viability was measured by MTT assay. Neutrophils incubated with RPMI (medium) alone or 50 μM H2O2 (Hydrogen Peroxide) were used as negative and positive control, respectively. Data shown as Neutrophil viability (%) ± S.D. p <0.01 when compared to Medium (*)

Since no cytotoxic effects were observed in leukocytes, other cytotoxicity assays were performed with E. punicifolia hydroethanolic extract solutions (HEEP) as well as with E. aurata hydroethanolic extract solutions (HEEA), using tumor and not tumor cell lines. As others [25], HEEP and HEEA (mean TGI > 141 μg/mL and 198 μg/mL, respectively) did not exhibit a cytotoxicity against all tested cell lines. HEEP presented a moderate selective activity effect against cell line K562 (leukemia, 12.9 ± 7.19 μg/mL) and weak for MCF-7 (mammary, 39.0 ± 5.80 μg/mL). For all the analyzed lineages, including normal cell VERO (Green monkey kidney), HEEP was inactive (Table 1). HEEA was inactive for the tested lineages, including normal cell VERO (Green monkey kidney).
Table 1

TGI values (Total Growth Inhibition, μg/mL) of Eugenia punicifolia and E. aurata hydroethanolic leaf extracts

Tested material

Cell linesa

 

u

M

a

7

4

p

o

h

k

V

Doxorubicinb

 

3.30

6.60

2.67

0.90

5.85

2.95

3.90

8.43

8.43

HEEPc

>250

39.0 ± 5.80

120.0 ± 0.97

>250

209.7 ± 3.26

47.6 ± 13,3

105 ± 53,7

124.7 ± 0.99

12.9 ± 7.19

>250

HEEAc

*

>250

>250

240 ± 0.14

78.5 ± 21.7

229 ± 64

*

>250

34.2 ± 9.7

>250

au = UACC (melanoma); m = MCF-7 (mammary); a = NCI-ADR/RES (drug resistant ovary); 7 = 786-0 (kidney); 4 = NCI-H460 (lung); p = PC-3 (prostate); o = OVCAR-3 (ovary); h = HT-29 (colon) V = VERO (Green monkey kidney). bPositive Control.cHEEP and HEEA – Ethanol:water 70:30 v/v extract. *not tested

According to ex vivo assays, E.aurata and E.punicifolia inhibit neutrophil functions in the absence of cell death. Based on these results, in vivo tests were performed. The in vivo experiment comprises a greater complexity of events when compared to in vitro and ex vivo experiments, in which experimental conditions are better monitored. Therefore, the results obtained using in vivo analyses are closer to the real scenario.

Acute peritonitis model induced by Thioglycolate in mice was assessed in order to evaluate Eugenia anti-inflammatory activity. Both extracts showed anti-inflammatory effect by inhibiting neutrophil influx. No animal showed symptoms of toxicity or even death. Mice received a subcutaneous injection of extract, and 1 h later were administered with 3 % Thioglycolate (TG) intraperitoneally. When mice are assayed in a peritonitis model, a 6 h period is necessary to reach maximum acute neutrophil recruitment. In vivo cell migration analysis showed that subcutaneous injection of different extracts concentrations significantly reduced cell influx into the peritoneal cavity (Fig. 5). EP showed anti-inflammatory activity at concentrations of 30 and 300 mg/mL (Fig. 5a). As for EA, the anti-inflammatory activity was observed for all the tested concentrations (Fig. 5b). As negative control, extracts were s.c. injected and PBS was i.p. injected. As a result, neutrophil migration did not occur. Either for EA as for EP, the anti-inflammatory activity was comparable to the effect of dexamethasone (DEX), a potent anti-inflammatory drug in clinical use.
Fig. 5

Eugenia extracts inhibit in vivo neutrophil migration. Swiss male mice previously injected (s.c.) with Eugenia aurata (EA; panel a) or E. punicifolia (EP; panel b), received i.p. injection of 3 % Thioglycolate (TG). Cellular migration was allowed for six hours when the peritoneal lavage fluid was collected and subjected to total and differential cell count. PBS group received = PBS (s.c. and i.p.); TG group received = PBS (s.c.) and TG (i.p.); TG/DEX group received = DEX (s.c.) and TG (i.p.). Data shown as in vivo migration (%) ± SD. (n = 5). # p <0.01 when compared to PBS; ** p <0.01 and *** p <0.001 when compared to TG

Differences in chemical composition between E. aurata and E. punicifolia HBK may explain the anti-inflammatory effects described herein. Both extracts inhibit NET release but only EA reduces cell adhesion whereas EP decreases elastase secretion.

The control of accute/chronic inflammatory processes as rheumatoid arthrite, ashtma, vaculitis among others like diabetes is relevant, once such processes may be related to the damage caused by the release of free radicals [26]. Moreover, neutrophil activation is largely dependent on the generation of reactive oxygen species (ROS) that are known to be inhibited by antioxidant compounds, as catechin and rutin, found abundantly in plant extracts [27]. Selected phenolic compounds, as diosmin and hesperidin, decrease the adhesion of inflammatory cells to the endothelium [28], whereas others can inhibit degranulation of neutrophils without affecting superoxide production [29].

E. punicifolia showed phenolic compounds concentrations of 74.86 ± 0.02 mg gallic acid/g extract and E. aurata 57.93 ± 0.05 mg gallic acid/g extract. Flavonoid content found was 32.00 ± 0.02 mg quercetin/g extract and 15.78 ± 0.01 mg quercetin/g extract, respectively.

Magina et al. [30] described, respectively, for Eugenia brasiliensis, E.umbelliflora and E.beaurepaireana hydroethanolic leaves extracts (70 %): 162.6 ± 3.3, 138.0 ± 2.7 to 128.1 ± 2.9 mg gallic acid/g. E. aurata and E. punicifolia showed lower phenol levels when compared to species studied by Magina et al. [30]. Although phenolic content found is lower than expected for E. punicifolia, flavonoid content approached similar levels to previous studies from Magina and collaborators [30]: E. brasiliensis, E. umbelliflora and E.beaurepaireana showed, respectively, 14.4 ± 1.1, 31.2 ± 1.7 and 10.4 ± 1.1 mg quercetin/g extract.

In addition, after assessing the phenolic and flavonoid contents, an ESI-MS was performed, in order to correlate the main secondary metabolites found in HEEP and in HEEA with their biological activity without further chromatographic separations, since a preliminary HPLC HEEP analysis was already published by our group [31]. Gallic acid derivatives, flavonols, glycosides and procyanidins were the most common phenolic compounds in fruits and leaves of the Myrtaceae family [32]. Database search showed no prior HEEA research published to the moment.

The most characteristic corresponding molecular formulas of HEEP and HEEA, their fractions, MS/MS fragments are shown in Table 2. All peaks found were tentatively assigned based on their accurate masses and MS/MS patterns. The peak at m/z 169 was assigned to gallic acid and confirmed by fragmentation of m/z 125 [M-44-H] because of CO2 loss [33]. The ion of m/z 191 represents quinic acid, frequently found in higher plant as major compounds in the leaves [34] showed fragments of m/z 173 after H2O loss [35]. The peak at m/z 359 was characterized as glycosyringic acid [36]. 3-Feruloylquinic acid (peak of m/z 367) was characterized according Fang et al. [37] and with fragment m/z 173 and diagnostic peak m/z 193 (hydroxymethoxycinnamoyl moiety). The peak at m/z 463 was characterized as mudanoside with fragments m/z 301 ([M-H-162]) lost glucose group [38].
Table 2

Phenolic compounds tentatively identified of Eugenia sp. leaf extracts

Formula [M-H]

Theoretical mass

Experimental mass [M – H]m/z

Δm (ppm)

MS/MS fragments m/z

Compound identification

HEEP

HEEA

EA

EP

C7H5O5

169,0142

169,0148

−1,49

151,125

gallic acid

HEEP

Ep

C7H10O6

191,0561

191,0561

0,06

173,134

quinic acid

HEEA

Ea

C7H11O6

197,0458

197,0461

−1,28

169, 140, 124

syringic acid

HEEP

Ep

C14H5O8

300,9990

300,9996

−1,69

284, 257, 229, 185

ellagic acid

HEEP HEEA

Ep

C13H15O10

331,0671

331,0670

−0,39

271, 211, 169

monogalloyl-glucose

HEEP HEEA

Ep

C15H20O10

359,0984

359,0979

1,31

271,169

Glycosyringic acid

HEEP

Ep

C17H19O9

367,1035

367,1050

0,29

326,193,173,134

3-Feruloylquinic acid

HEEA

 

C19H13O12

433,0412

433,0423

−2,11

300,169, 125

Ellagic acid xyloside

HEEP

 

C20H17O11

433,0776

433,0768

2,52

300,271,169

Quercetin-3-O-α − arabinopyranoside

HEEP

Ep

C21H19O11

447,0933

447,0936

−0,7

301, 271,151

Quercetin-3-O-β − rhamnose

HEEP HEEA

Ep Ea

C21H19O12

463,0880

463,0882

0,43

317, 271, 179

myricitrin

HEEA HEEP

Ea

C18 H23O14

463,1166

463,1086

1,19

301, 169

Mudanoside B

HEEP

Ep

C20H17O14

481,0624

481,0642

−3,78

447, 301, 275, 211,169

HHDP glucose isomer

HEEP

Ep

C23H31O11

483,1872

483,1858

2,16

447, 331,169

Digalloylglucose isomer

HEEP

Ep

C27H30O15

593,1502

593,1547

1,67

415, 341, 284,103

rutinosylkaempferol

HEEA

 

C27H19O14

609,1480

609,1461

−3,1

511, 300, 151

Rutin

HEEA

Ea

C39H19O8

615,1087

615,1086

−0,1

463, 301, 241, 169

Quercetin galloylhexoside isomer

HEEP

Ea Ep

C34H24O22

783,0686

783,0681

0,7

481, 381, 275

bis HHDP-glucose isomer

HEEP

 

Ep = E. punicifolia; Ea = E. aurata (HEEP and HEEA fraction soluble in ethanolic solution)

Monogalloylglucose with its m/z 331 [M - H] ion dissociating to yield an m/z 169 ion after a glucosyl group loss ([M-H-162]) [39]. Digalloylglucose with its m/z 483 [M - H] ion dissociating to yield an m/z 169 ion after sequential removal of a galloyl group ([M-H-152]) and a glucosyl group ([M-H-162]) [40].

HEEP and HEEA diagnostic mass fragments m/z 301 and m/z 317 were characterized as quercetin and myricetin, respectively. The neutral losses of 132, 146 and 162 mass units allowed the identification of pentosides (xylose or arabinose), hexosides (glucose or galactose) and deoxyhexoside. Gallic acid was diagnosed by a neutral loss of 152 mass units. Peaks at m/z 433, 447, 463, 593, 609, and 615 were assigned as flavonols and their derivatives. The quercetin pentoside isomer at m/z 433 [M – H] produced the MS/MS fragmentation of m/z 300 [M - H-132], due the loss of arabinopyranoside. The ion at m/z 447 was tentatively assigned to quercetin-3-O-β-rhamnose. The MS/MS fragmentation produced a deprotonated aglycone ion at m/z 301 [M-146-H] due loss a sugar moiety of 146 Da and m/z 271 typical of flavon-3-O-monoglycoside [41] and 179 from RDA of ring A. Two isomeric compounds ions observed with [M–H] at m/z 463, whose MS/MS main fragmentation produced a deprotonated aglycone form myricetin ion at m/z 317 [M-146-H] (loss of a sugar moiety of 146 units), indicates that the compound is a myricetin monohexoside (myricetin 3-O-galactoside or myricetin 3-O-rhamnoside) and another isomer peak ion at m/z 301 with its [M-162-H] (loss of a sugar moiety of 162 units), an indicative of quercetin monohexoside, and the hexose could be glucoside or galactoside [42]. Dissociation of fragment m/z 593 showed a loss of 308 units (corresponding to a rhamnose plus glucose group) and yielded directly a fragment ion at m/z 285 (assigned as kaempferol).

Compared to flavonoid glycosides found in gingko biloba [43], we tentatively characterized the compound as kaempferol-3-O- glucose- rhamnoside. Fragmentation of the compound at m/z 609 produced an ion at m/z 301, attributed to [M-H-146–162]– through loss of 308 units from a rhamnose (146 u) plus a glucose (162 u), indicating the compound is a rutin.

At m/z 615, the MS/MS peak fragmentation produced an ion at m/z 463 [M-152-H] (loss of the galloyl moiety) and a deprotonated quercetin at m/z 301 [M-162-H] (loss of a sugar moiety of 162 units), indicative of quercetin-3-O-β-(6”galloyl) hexose. These flavonols derivatives have been previously reported in other Eugenia species and they are usually associated to antioxidant and antiproliferative activities [34, 39].

Some phenolic compounds found in HEEP/HEEA extracts belong to the family of ellagitannins. They are hydrolyzable tannins, a class of polyphenols whose structure consists of ellagic acid units linked to a polyol, usually glucose or quinic acid. These compounds are also characterized by their hexahydroxydiphenoyl (HHDP) group which is released on acid hydrolysis and spontaneously lactonizes to ellagic acid. Ellagic acid was characterized by diagnostic mass ion of m/z 301 and ma ss fragments at m/z 257 and 229 [40]. Ellagic acid xyloside was characterized by ion of m/z 301[M-162-H] (loss of glucose plus H2O, 162 units).

HHDP-glucose isomers were assigned as a signal at m/z 481[M-162–18-H] (loss of glucose plus H2O, 180 units) [33]. However, ellagitannins had lower efficacy in the inhibition of cell proliferation compared to ellagic acid, the breakdown product [44].

At m/z 783, the MS2 peak fragmentation produced an ion at m/z 481 [M-H-302], loss of HHDP), and after losing a HHDP-glucose [M–H-481], an ion at m/z 301 which corresponds to ellagic acid. This fragmentation pattern was assigned to a bis-HHDP-glucose isomer. Additionally there were peaks at m/z 481 [M-H-469], loss of a trisgalloyl group) and m/z 301, corresponding to ellagic acid. These results suggest a HDDP-glucose and a trigalloyl group. All those results are consistent with data reported for other Eugenia [42, 45].

Table 2 shows that EA contains the phenolic compounds myricitrin, rutin, quinic acid and quercetin derivatives. Among those compounds, some present a role on neutrophil activity. Aqueous extract containing quinic acid or its molecule derivate are described to inhibit neutrophil migration [46] and elastase secretion [47]. Despite inhibitory roles demonstrated for myricetin in elastase secretion [48], its derivate myricitrin does not present any inhibitory effect [49]. The suppressor character of rutin on neutrophil functions were better studied than the compounds cited above. Isolated rutin or the one found in plant extracts decreases in vitro and in vivo neutrophil migration [50], adhesion [51], elastase secretion [52] and NET release [27]. Quercetin derivatives were commonly found in E.aurata and E.punicifolia extract fractions. There are no evidences that quercetin-3-O-β-rhamanose or quercetin-galloyl-hexoside promotes effects on neutrophil activities. In contrast, quercetin suppresses elastase secretion [48] and in vivo and in vitro neutrophil migration [20]. The role of quercetin in the adhesion events is still unclear [53].

ESI-MSn analyses also revealed the presence of gallic acid, quercetin-3-O-α-arabinopyranoside, syringic acid, ellagic acid, monogalloyl-glucose, glycosyringic acid, mudanoside B, HHDP glucose isomer and digalloylglucose isomer. The participation of these compounds in the neutrophil biology is poorly studied. There were reported downregulation of elastase secretion, NET release and neutrophil migration for gallic and ellagic acids present in plant extracts or in isolated form [53]. Evidences were not found for neutrophil adhesion.

Conclusions

Based in our results, we are able to propose a model for the anti-inflammatory properties exhibited by both hydroethanolic extracts of E. aurata and E. punicifolia (Fig. 6). The extracts in this model have a different chemical composition in terms of phenolic compounds, but both present in vivo and ex vivo anti-inflammatory activity, besides not being toxic to neutrophils. E. aurata reduces neutrophil adhesion and E. punicifolia decreases elastase degranulation. NET release is inhibited by both extracts ex-vivo. Together, these effects result on a reduced inflammatory response and provide support to their use in popular medicine. Furthermore, these results show a potential of these extracts for the development of phytomedicines with anti-inflammatory properties, including the treatment of rheumatology, neoplastic, self-inflammatory, autoimmune or infectious disorders.
Fig. 6

Schematic summary of Eugenia aurata and E. punicifolia effects on neutrophil recruitment. EA affects mainly adhesion whereas EP, degranulation. Both extracts cease NETs release

Abbreviations

DEX: 

Dexamethasone

DMSO: 

Dimethyl Sulfoxide

EA: 

E. aurata hydroethanolic extract fraction soluble in PBS

EP: 

E.punicifolia hydroethanolic extract fraction soluble in PBS

ESI-MS: 

Electrospray ionization mass spectrometry

FBS: 

Fetal bovine serum

HEEA: 

E. aurata hydroethanolic extract solutions

HEEP: 

E. punicifolia hydroethanolic extract solutions

HPLC: 

High performance liquid chromatography

MTT: 

3-(4,5-dimethylthiazol-2-yl) 2,5-Diphenyl Tetrazolium bromide

NETs: 

Neutrophil extracellular traps

PBS: 

Phosphate Buffer Solution

PMA: 

Phorbol myristate acetate

TG: 

Thioglycolate

TGI: 

Total growth inhibition.

Declarations

Acknowledgments

The authors acknowledge the biomedical Ivan Vicente Nascimento, the nurse Roseli Aparecida Vezenfard Soto and the Health Technical Section (FCL-Unesp) for their valuable help in blood sample acquisition. Also, Diogo Pessoa and Pedro Sampaio for english review.

Funding

This work was financially supported by Federal Brazilian agency CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior).

Availability of data and materials

We have presented our primary data in the form of figure and tables. The datasets supporting the conclusions of this article are included within the article.

Authors’ contributions

Conceived and designed the experiments: MFC, TIJ, BRPL, CFFA, AM, LPG, GSP, ALTGR, JEC, MNE, CS, KAT. Performed the experiments: MFC, TIJ, BRPL, CFFA, AM, LPG, GSP, ALTGR, JEC, MNE, CS. Analyzed the data: MFC, TIJ, BRPL, CFFA, AM, LPG, GSP, ALTGR, JEC, MNE, CS, KAT. Contributed reagents/materials/analysis tools: CFFA, ALTGR, JEC, MNE, CS, KAT. Wrote the paper: MFC, TIJ, BRPL, CFFA, ALTGR, JEC, MNE, CS, KAT. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

All study participants provided informed consent for the data publication.

Ethics approval and consent to participate

Animal study was approved at the Animal Research Facility of the Faculdade de Ciências e Letras de Assis (FCLA) - UNESP. Proper authorization from the Ethics Committee (process no. 017/2012) permitted in vivo use of mice for neutrophil migration studies. For neutrophil isolation, the Ethics Committee on Human Research of the Faculdade de Ciências e Letras de Assis (FCLA) -, UNESP, approved the experimental protocol (number 02073912.0.0000.5401). All participants provided written informed consent to participate in the study.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Departamento de Ciências Biológicas, Faculdade de Ciências e Letras, Universidade Estadual Paulista -UNESP
(2)
ThoMSon Laboratório de Espectrometria de Massas, Instituto de Química, Universidade Estadual de Campinas (UNICAMP)
(3)
Centro Pluridisciplinar de Pesquisas Químicas, Biológicas e Agrícolas, UNICAMP
(4)
Faculdade de Ciências Farmacêuticas, Universidade Estadual de Campinas (UNICAMP)

References

  1. Kruger P, Saffarzadeh M, Weber AN, Rieber N, Radsak M, von Bernuth H, et al. Neutrophils: Between host defence, immune modulation, and tissue injury. PLoS Pathog. 2015;11(3):e1004651. doi:10.1371/journal.ppat.1004651.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Baliga MS. Anticancer, chemopreventive and radioprotective potential of black plum (Eugenia jambolana lam.). Asian Pac J Cancer Prev. 2011;12(1):3–15.PubMedGoogle Scholar
  3. Rizvi SI, Mishra N. Traditional Indian medicines used for the management of diabetes mellitus. J Diab Res. 2013;2013:712092. doi:10.1155/2013/712092.Google Scholar
  4. Lopes Galeno DM, Carvalho RP, Boleti AP, Lima AS, de Almeida PD O, Pacheco CC, et al. Extract from Eugenia punicifolia is an antioxidant and inhibits enzymes related to metabolic syndrome. Appl Biochem Biotechnol. 2014;172(1):311–24. doi:10.1007/s12010-013-0520-8.View ArticlePubMedGoogle Scholar
  5. Meyre-Silva C, Petry CM, Berte TE, Becker RG, Zanatta F, Delle-Monache F, et al. Phytochemical analyses and gastroprotective effects of Eugenia umbelliflora (Myrtaceae) on experimental gastric ulcers. Nat Prod Commun. 2009;4(7):911–6.PubMedGoogle Scholar
  6. Leite PE, de Almeida KB, Lagrota-Candido J, Trindade P, da Silva RF, Ribeiro MG, et al. Anti-inflammatory activity of Eugenia punicifolia extract on muscular lesion of mdx dystrophic mice. J Cell Biochem. 2010;111(6):1652–60. doi:10.1002/jcb.22906.View ArticlePubMedGoogle Scholar
  7. Costa TR, Fernandes OF, Santos SC, Oliveira CM, Liao LM, Ferri PH, et al. Antifungal activity of volatile constituents of Eugenia dysenterica leaf oil. J Ethnopharmacol. 2000;72(1-2):111–7.View ArticlePubMedGoogle Scholar
  8. Grangeiro MS, Calheiros-Lima AP, Martins MF, Arruda LF, Garcez-do-Carmo L, Santos WC. Pharmacological effects of Eugenia punicifolia (Myrtaceae) in cholinergic nicotinic neurotransmission. J Ethnopharmacol. 2006;108(1):26–30. doi:10.1016/j.jep.2006.04.021.View ArticlePubMedGoogle Scholar
  9. Tenfen A, Siebert DA, Yamanaka CN, Mendes de Cordova CM, Scharf DR, Simionatto EL et al. Chemical composition and evaluation of the antimicrobial activity of the essential oil from leaves of Eugenia platysema. Nat Prod Res. 2015:1-5. doi:10.1080/14786419.2015.1107056
  10. Maia JGS. Plantas aromáticas na Amazônia e seus óleos essenciais. Pará - Brasil: Museu Paraense Emílio Goeldi; 2001. Google Scholar
  11. Chaves E, Barros R. Diversidade e uso de recursos medicinais do carrasco na APA da Serra da Ibiapaba, Piauí, Nordeste do Brasil. Rev Bras Plantas Med. 2012;14(3):476–86.View ArticleGoogle Scholar
  12. Silva SR. Plantas do cerrado utilizadas pelas comunidades da região do Grande Sertão Veredas. Brasília - Brasil: Funatura, Fundação Pró-Natureza, 1998.Google Scholar
  13. Environment Mo. The state of the world's forest genetic resources, vol. 1. Brasília- Brazil: Minister of Environment;  2012. (acessed)Google Scholar
  14. Garber JC, Barbee RW, Bielitzki JT, Clayton L, Donovan J, Hendriksen C, et al. Guide for the care and use of laboratory animals, vol. 8. Washington: The National Academic Press; 2011. p. 220.Google Scholar
  15. Kabeya LM, Kanashiro A, Azzolini AE, Soriani FM, Lopes JL, Lucisano-Valim YM. Inhibitory effect of eight simple coumarins on the lucigenin enhanced chemiluminescence of rabbit neutrophils. Res Commun Mol Pathol Pharmacol. 2002;111(1-4):103–13.PubMedGoogle Scholar
  16. Lucisano YM, Mantovani B. Lysosomal enzyme release from polymorphonuclear leukocytes induced by immune complexes of IgM and of IgG. J Immunol. 1984;132(4):2015–20.PubMedGoogle Scholar
  17. Stocco B, Toledo K, Salvador M, Paulo M, Koyama N, Torqueti Toloi MR. Dose-dependent effect of resveratrol on bladder cancer cells: chemoprevention and oxidative stress. Maturitas. 2012;72(1):72–8. doi:10.1016/j.maturitas.2012.02.004.View ArticlePubMedGoogle Scholar
  18. Sousa-Rocha D, Thomaz-Tobias M, Diniz LF, Souza PS, Pinge-Filho P, Toledo KA. Trypanosoma cruzi and Its Soluble Antigens Induce NET Release by Stimulating Toll-Like Receptors. PLoS One. 2015;10(10):e0139569. doi:10.1371/journal.pone.0139569.View ArticlePubMedPubMed CentralGoogle Scholar
  19. de Toledo KA, Bernardes ES, Baruffi MD, Roque-Barreira MC. Neutrophil haptotaxis induced by mouse MNCF: interactions with extracellular matrix glycoproteins probably contribute to overcoming the anti-inflammatory action of dexamethasone. Inflamm Res. 2007;56(9):368–76. doi:10.1007/s00011-007-6159-6.View ArticlePubMedGoogle Scholar
  20. Souto FO, Zarpelon AC, Staurengo-Ferrari L, Fattori V, Casagrande R, Fonseca MJ, et al. Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization. J Nat Prod. 2011;74(2):113–8. doi:10.1021/np1003017.View ArticlePubMedGoogle Scholar
  21. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst. 1991;83(11):757–66.View ArticlePubMedGoogle Scholar
  22. Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer. 2006;6(10):813–23. doi:10.1038/nrc1951.View ArticlePubMedGoogle Scholar
  23. Kalia K, Sharma K, Singh HP, Singh B. Effects of extraction methods on phenolic contents and antioxidant activity in aerial parts of Potentilla atrosanguinea Lodd. and quantification of its phenolic constituents by RP-HPLC. J Agric Food Chem. 2008;56(21):10129–34. doi:10.1021/jf802188b.View ArticlePubMedGoogle Scholar
  24. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159–75. doi:10.1038/nri3399.View ArticlePubMedGoogle Scholar
  25. Fouche G, Cragg GM, Pillay P, Kolesnikova N, Maharaj VJ, Senabe J. In vitro anticancer screening of South African plants. J Ethnopharmacol. 2008;119(3):455–61. doi:10.1016/j.jep.2008.07.005.View ArticlePubMedGoogle Scholar
  26. Degáspari C, Waszczynskyj N. Antioxidants properties of phenolic compounds. Visão Acadêmica. 2004;5(1):33–40.View ArticleGoogle Scholar
  27. Kirchner T, Hermann E, Moller S, Klinger M, Solbach W, Laskay T, et al. Flavonoids and 5-aminosalicylic acid inhibit the formation of neutrophil extracellular traps. Mediat Inflamm. 2013;2013:710239. doi:10.1155/2013/710239.View ArticleGoogle Scholar
  28. Friesenecker B, Tsai AG, Intaglietta M. Cellular basis of inflammation, edema and the activity of Daflon 500 mg. Int J Microcirc Clin Exp. 1995;15 Suppl 1:17–21.PubMedGoogle Scholar
  29. Ferrandiz ML, Gil B, Sanz MJ, Ubeda A, Erazo S, Gonzalez E, et al. Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice. J Pharm Pharmacol. 1996;48(9):975–80.View ArticlePubMedGoogle Scholar
  30. Magina MA, Gilioli A, Moresco HH, Colla G, Pizzolatti MG, Brighente IM. Atividade antioxidante de três espécies de Eugenia (Myrtaceae). Lat Am J Pharm. 2010;29(3):376–82.Google Scholar
  31. Basting RT, Nishijima CM, Lopes JA, Santos RC, Lucena Perico L, Laufer S, et al. Antinociceptive, anti-inflammatory and gastroprotective effects of a hydroalcoholic extract from the leaves of Eugenia punicifolia (Kunth) DC. in rodents. J Ethnopharmacol. 2014;157:257–67. doi:10.1016/j.jep.2014.09.041.View ArticlePubMedGoogle Scholar
  32. Simirgiotis MJ, Borquez J, Schmeda-Hirschmann G. Antioxidant capacity, polyphenolic content and tandem HPLC-DAD-ESI/MS profiling of phenolic compounds from the South American berries Luma apiculata and L. chequen. Food Chem. 2013;139(1-4):289–99. doi:10.1016/j.foodchem.2013.01.089.View ArticlePubMedGoogle Scholar
  33. Regueiro J, Sanchez-Gonzalez C, Vallverdu-Queralt A, Simal-Gandara J, Lamuela-Raventos R, Izquierdo-Pulido M. Comprehensive identification of walnut polyphenols by liquid chromatography coupled to linear ion trap-Orbitrap mass spectrometry. Food Chem. 2014;152:340–8. doi:10.1016/j.foodchem.2013.11.158.View ArticlePubMedGoogle Scholar
  34. Oliveira AL, Destandau E, Fougere L, Lafosse M. Isolation by pressurised fluid extraction (PFE) and identification using CPC and HPLC/ESI/MS of phenolic compounds from Brazilian cherry seeds (Eugenia uniflora L.). Food Chem. 2014;145:522–9. doi:10.1016/j.foodchem.2013.08.065.View ArticlePubMedGoogle Scholar
  35. Fitzpatrick DF, Fleming RC, Bing B, Maggi DA, O'Malley RM. Isolation and characterization of endothelium-dependent vasorelaxing compounds from grape seeds. J Agric Food Chem. 2000;48(12):6384–90.View ArticlePubMedGoogle Scholar
  36. Ninh PT, Nhung LTH, Sung TV, Cuong NH, Thuy TT. Isolation and structural characterization of Phenolic glycoside and Triterpenes in Celastrus hindsii Benth. VJ Chem. 2008; 46(2).Google Scholar
  37. Fang N, Yu S, Prior RL. LC/MS/MS characterization of phenolic constituents in dried plums. J Agric Food Chem. 2002;50(12):3579–85.View ArticlePubMedGoogle Scholar
  38. Lin H-C, Ding H-Y, Wu Y-C. Two Novel Compounds from Paeonia s uffruticosa. J Nat Prod. 1998;61(3):343–6.View ArticlePubMedGoogle Scholar
  39. Serna DM, Martinez JH. Phenolics and Polyphenolics from Melastomataceae Species. Molecules. 2015;20(10):17818–47. doi:10.3390/molecules201017818.View ArticlePubMedGoogle Scholar
  40. Lee JH, Johnson JV, Talcott ST. Identification of ellagic acid conjugates and other polyphenolics in muscadine grapes by HPLC-ESI-MS. J Agric Food Chem. 2005;53(15):6003–10. doi:10.1021/jf050468r.View ArticlePubMedGoogle Scholar
  41. Ablajan K, Abliz Z, Shang XY, He JM, Zhang RP, Shi JG. Structural characterization of flavonol 3,7-di-O-glycosides and determination of the glycosylation position by using negative ion electrospray ionization tandem mass spectrometry. J Mass Spectrom. 2006;41(3):352–60. doi:10.1002/jms.995.View ArticlePubMedGoogle Scholar
  42. Sales DS, Carmona F, de Azevedo BC, Taleb-Contini SH, Bartolomeu AC, Honorato FB, et al. Eugenia punicifolia (Kunth) DC. as an adjuvant treatment for type-2 diabetes mellitus: a non-controlled, pilot study. Phytother Res. 2014;28(12):1816–21. doi:10.1002/ptr.5206.View ArticlePubMedGoogle Scholar
  43. Zhou H, Tang W, Zeng J, Tang C. Screening of terpene lactones and flavonoid glycosides in Gingko biloba capsule by UPLC-Orbitrap high resolution MS, with emphasis on isomer differentiation. J Food Nutr Res. 2014;2(7):369–76.View ArticleGoogle Scholar
  44. Pinto Mda S, de Carvalho JE, Lajolo FM, Genovese MI, Shetty K. Evaluation of antiproliferative, anti-type 2 diabetes, and antihypertension potentials of ellagitannins from strawberries (Fragaria x ananassa Duch.) using in vitro models. J Med Food. 2010;13(5):1027–35. doi:10.1089/jmf.2009.0257.View ArticlePubMedGoogle Scholar
  45. Yang LL, Lee CY, Yen KY. Induction of apoptosis by hydrolyzable tannins from Eugenia jambos L. on human leukemia cells. Cancer Lett. 2000;157(1):65–75.View ArticlePubMedGoogle Scholar
  46. Schinella G, Neyret E, Console G, Tournier H, Prieto JM, Rios JL, et al. An aqueous extract of Ilex paraguariensis reduces carrageenan-induced edema and inhibits the expression of cyclooxygenase-2 and inducible nitric oxide synthase in animal models of inflammation. Planta Med. 2014;80(12):961–8. doi:10.1055/s-0034-1382876.View ArticlePubMedGoogle Scholar
  47. Benedek B, Kopp B, Melzig MF. Achillea millefolium L. s.l. -- is the anti-inflammatory activity mediated by protease inhibition? J Ethnopharmacol. 2007;113(2):312–7. doi:10.1016/j.jep.2007.06.014.View ArticlePubMedGoogle Scholar
  48. Kanashiro A, Souza JG, Kabeya LM, Azzolini AE, Lucisano-Valim YM. Elastase release by stimulated neutrophils inhibited by flavonoids: importance of the catechol group. Z Naturforsch C. 2007;62(5-6):357–61.View ArticlePubMedGoogle Scholar
  49. Xu GH, Ryoo IJ, Kim YH, Choo SJ, Yoo ID. Free radical scavenging and antielastase activities of flavonoids from the fruits of Thuja orientalis. Arch Pharm Res. 2009;32(2):275–82. doi:10.1007/s12272-009-1233-y.View ArticlePubMedGoogle Scholar
  50. Chen WY, Huang YC, Yang ML, Lee CY, Chen CJ, Yeh CH, et al. Protective effect of rutin on LPS-induced acute lung injury via down-regulation of MIP-2 expression and MMP-9 activation through inhibition of Akt phosphorylation. Int Immunopharmacol. 2014;22(2):409–13. doi:10.1016/j.intimp.2014.07.026.View ArticlePubMedGoogle Scholar
  51. Suyenaga ES, Klein-Junior LC, Passos Cdos S, Marin R, Santin JR, Machado ID, et al. Beyond organoleptic characteristics: the pharmacological potential of flavonoids and their role in leukocyte migration and in L-selectin and beta2-integrin expression during inflammation. Phytother Res. 2014;28(9):1406–11. doi:10.1002/ptr.5144.View ArticlePubMedGoogle Scholar
  52. Vasange M, Liu B, Welch CJ, Rolfsen W, Bohlin L. The flavonoid constituents of two Polypodium species (Calaguala) and their effect on the elastase release in human neutrophils. Planta Med. 1997;63(6):511–7. doi:10.1055/s-2006-957753.View ArticlePubMedGoogle Scholar
  53. Suri S, Taylor MA, Verity A, Tribolo S, Needs PW, Kroon PA, et al. A comparative study of the effects of quercetin and its glucuronide and sulfate metabolites on human neutrophil function in vitro. Biochem Pharmacol. 2008;76(5):645–53. doi:10.1016/j.bcp.2008.06.010.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement